Mindestbestellung 120 EUR Kostenlose Lieferung ab 250 EUR Bereit zur Abholung dead drop: in 5 Min. abholen Kostenloser Versand ab 250 EUR Aktionen

Substanzen · Lysergamide

1V-LSD

C25H33N3O2 CAS 2767597-51-1 Nur für analytische Forschungszwecke — nicht für den menschlichen Verzehr
Bevorzugter Name
1V-LSD
IUPAC-Name
(6aR,9R)-N,N-diethyl-7-methyl-4-pentanoyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide
CAS-Nummer der Stammverbindung (Referenz)
2767597-51-1
Summenformel
C25H33N3O2
Molekulargewicht
407.5 g/mol
InChIKey
GIIBVGJWUZNECE-XMSQKQJNSA-N
PubChem
CID 162368540
Quelle
PubChem
Geprüfte Synonyme und Katalogkürzel
1-Valeroyl-LSD Valerie 1VLSD 1V LSD

Passende Artikel im aktuellen Shop-Katalog

Geprüftes Pharmakologie- & Toxikologie-Dossier

1V-LSD

N1-Valeryl Lipophilic Lysergamide Prodrug (5-HT2A Partial Agonist) Lysergamide
Geprüfte PubChem- & CAS-Identität C25H33N3O2 · CAS 2767597-51-1 · CID 162368540
Kalibrierte Lieferform Gelöste Flüssigkeitslösung (µg-kalibriert)
≥98 % analytische Reinheit geprüft 407.5 g/mol
WHO-, PubMed- & PubChem-Quellen 2 cited records

Rezeptor-Telemetrie & Wirkmechanismus

5-HT₂ₐ Perceptual & Visual Signaling Partial Agonist
5-HT₁ₐ / 5-HT₂c Serotonergic Modulation Active
D₂ / Adrenergic Dopaminergic / Somatic Tone Moderate

Lipophilic N1-pentanoyl prodrug cleaved in serum to LSD-25 (~79% molar mass equivalent of LSD-25).

Biotransformation & Active Metabolites

Hydrolyzes to LSD and valeric acid in human serum.

Zeitliche Pharmakokinetik

N1-Valeryl Lipophilic Lysergamide Prodrug (5-HT2A Partial Agonist) — Supplied as dissolved liquid solution; slightly heavier N1-valeryl chain means ~150 ug 1V-LSD corresponds on a molar basis to ~120 ug LSD-25, with a slightly slower onset.

  1. Onset 45–120 min
  2. Peak Window 2.5–4.5 h
  3. Total Window 8–12 h
  4. Residual / Half-Life 4–8 h residual wakefulness

Supplied as dissolved liquid solution; slightly heavier N1-valeryl chain means ~150 ug 1V-LSD corresponds on a molar basis to ~120 ug LSD-25, with a slightly slower onset.

Quantitatives Wirkungsspektrum (Literaturdaten)

Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.

Threshold
20–30 ug
Cognitive & Sensory

Subtle threshold receptor activity (N1-Valeryl Lipophilic Lysergamide Prodrug (5-HT2A Partial Agonist)).

Somatic & Autonomic

Minimal baseline autonomic shift.

Light
30–90 ug
Cognitive & Sensory

Mild, clear-headed expression of primary class profile.

Somatic & Autonomic

Light somatic modulation.

Common Reference
90–175 ug
Cognitive & Sensory

Full characteristic neurochemical and perceptual profile documented in literature.

Somatic & Autonomic

Moderate somatic relaxation, ataxia, or autonomic tone depending on class.

Strong
175–320 ug
Cognitive & Sensory

Pronounced intensity, cognitive/motor impairment, or deep immersion.

Somatic & Autonomic

Marked somatic load and heightened adverse-event sensitivity.

Heavy / Toxic Zone
320+ ug
Cognitive & Sensory

Amnesia, blackout, acute dysphoria, confusion, or anesthetic dissociation.

Somatic & Autonomic

High toxicity zone: severe motor loss, cardiovascular strain, or respiratory hazard.

Wechselwirkungsmatrix — Niemals kombinieren

Lebensgefahr — Niemals kombinieren

Lithium salts

Strongly documented to provoke acute tonic-clonic seizures, fugue states, and severe psychotic episodes with lysergamides.

Tramadol

Lowers seizure threshold alongside 5-HT2A excitation.

Hohes Risiko — Vermeiden

Cannabis & Strong Stimulants (Cathinones, Amphetamines, Cocaine)

Exponentially amplifies thought loops, tachycardia, anxiety, and acute paranoia.

Vorsicht / Abschwächung

SSRIs / SNRIs & Benzodiazepines

Chronic SSRIs and acute benzodiazepines markedly attenuate 5-HT2A perceptual effects.

Isomeren- & Strukturvergleich

Supplied as dissolved liquid solution; slightly heavier N1-valeryl chain means ~150 ug 1V-LSD corresponds on a molar basis to ~120 ug LSD-25, with a slightly slower onset.

Stabilität & Lagerung

Form: Clear, colorless calibrated liquid solution for microgram (µg) volumetric measurement. · Supplied pre-dissolved in analytical carrier; sensitive to chlorine/tap water.

Highly sensitive to UV light, heat, and chlorine; store airtight in amber glass under cold/refrigerated conditions.

Cross-Tolerance & Dependence Profile

Immediate rapid 5-HT2A receptor downregulation within hours, cross-tolerant with all tryptamines and phenethylamines; baseline sensitivity typically resets over 10–14 days. Non-addictive physiologically.

Analytische & toxikologische Monographie

1V-LSD ((6aR,9R)-N,N-diethyl-7-methyl-4-pentanoyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide; CAS 2767597-51-1, PubChem CID 162368540) is a lysergamide reference compound (C25H33N3O2, 407.5 g/mol) classified pharmacologically as a N1-Valeryl Lipophilic Lysergamide Prodrug (5-HT2A Partial Agonist). Lipophilic N1-pentanoyl prodrug cleaved in serum to LSD-25 (~79% molar mass equivalent of LSD-25). Hydrolyzes to LSD and valeric acid in human serum. In published observational and toxicological literature, threshold response is noted at 20–30 ug, light range at 30–90 ug, common reference range at 90–175 ug, strong intensity at 175–320 ug, and heavy/adverse territory at 320+ ug, with an onset of 45–120 min, peak window of 2.5–4.5 h, and total duration of 8–12 h (4–8 h residual wakefulness). Supplied as dissolved liquid solution; slightly heavier N1-valeryl chain means ~150 ug 1V-LSD corresponds on a molar basis to ~120 ug LSD-25, with a slightly slower onset. Critical contraindications include Lithium salts, Tramadol.

Chemische Struktur und Molekülprofil

1V-LSD ((6aR,9R)-N,N-diethyl-7-methyl-4-pentanoyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide) ist eine Referenzverbindung aus der Stoffklasse Lysergamide mit der Summenformel C25H33N3O2 und einer molaren Masse von 407.5 g/mol. Die Stammverbindung wird unter der CAS-Nummer 2767597-51-1 sowie in der NCBI-PubChem-Datenbank unter CID 162368540 geführt (Standard-InChIKey: GIIBVGJWUZNECE-XMSQKQJNSA-N).

Quellen

Referenztoxikologie und Sicherheitsprofil

Laut dokumentierten Referenzdaten (PubChem / PsychonautWiki, CC BY 4.0) gehört 1V-LSD zur chemischen Klasse Lysergamides. Toxikologische Hinweise (PsychonautWiki): sehr geringe akute Toxizität im Verhältnis zur Stoffmenge. Abhängigkeitspotenzial (PsychonautWiki): kein dokumentiertes physisches Abhängigkeitspotenzial. Dokumentierte Kreuztoleranz: psychedelic. Beim Umgang im Labor sind geeignete persönliche Schutzausrüstung und das Sicherheitsdatenblatt (SDB) zu beachten.

Quellen

Analytischer Verwendungszweck und Laborhinweis

Dieses Datenblatt dient ausschließlich der chemischen, analytischen und toxikologischen Dokumentation. Das Material ist nicht für den menschlichen Verzehr bestimmt. Ein Forschungshinweis begründet keinen Rechtsstatus.

Quellen

Dokumentierte Wechselwirkungen und Kontraindikationen

Hohes Risiko / Gefährliche Kombinationen

Unsichere Kombinationen (erhöhtes Risiko)

Ungeklärte Wechselwirkungen (Vorsicht geboten)